About Sexual Desire in Postmenopausal Women

This research study is evaluating a new non-hormonal investigational drug to see if it may impact the frequency of satisfaction the women who participate may experience. In addition to possible access to this investigational drug, study participation offers eligible postmenopausal women:

• The chance to consult with a study doctor about their troubling loss of sexual desire.
• Access to women's research professionals to discuss study participants' distress due to reduced interest in sex.

SEE IF THERE'S A STUDY CLINIC NEAR YOU.

Participation in this research study will last up to 32 weeks. During this time, participants will:

• Have regular discussions with study professionals about their distress due to reduced sexual desire.
• Have a 1-in-2 (50%) chance of receiving either the investigational drug or placebo (an inactive substance designed to look like the investigational drug).

SEE IF YOU MAY BE ELIGIBLE.